Cargando…
Ectopic adrenocorticotrophic hormone syndrome secondary to treatment-related neuroendocrine differentiation of metastatic castrate-resistant prostate cancer
SUMMARY: A 64-year-old man with progressive metastatic castrate-resistant prostate adenocarcinoma presented with recurrent fluid overload, severe hypokalaemia with metabolic alkalosis and loss of glycaemic control. Clinical features were facial plethora, skin bruising and proximal myopathy. Plasma a...
Autores principales: | Tan, Chelsea, Triay, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874952/ https://www.ncbi.nlm.nih.gov/pubmed/36625254 http://dx.doi.org/10.1530/EDM-22-0347 |
Ejemplares similares
-
Denosumab-induced hypocalcaemia in metastatic castrate-resistant prostate cancer
por: Gunawan, Florence, et al.
Publicado: (2019) -
Posterior reversible encephalopathy syndrome in a patient with a metastatic pancreatic neuroendocrine tumour and ectopic Cushing’s syndrome
por: Palmer, Kieran, et al.
Publicado: (2021) -
A unique case of ectopic Cushing’s syndrome from a thymic neuroendocrine carcinoma
por: Lawrence, Lima, et al.
Publicado: (2019) -
Metastatic medullary thyroid carcinoma presenting as ectopic Cushing’s syndrome
por: Forde, Hannah E, et al.
Publicado: (2021) -
De novo purely prostatic large-cell neuroendocrine carcinoma with thyroid and adrenal metastases
por: Karvounis, Evangelos, et al.
Publicado: (2022)